Team

Unser interdisziplinäres Team besteht im Kern aus 25 PIs und 18 teilnehmenden Forschern (PRs), die ihre Expertise ergänzen. Junge, unabhängige Forschungsgruppenleiter bringen ihre frische Perspektive über 13 nextGENERATION-Forscherstellen ein.

Principal Investigators (PIs)

Andreas Keller

Sven Rahmann

Andrea Volkamer

Aranzazu del Campo

Jochen Hub

Franziska Lautenschläger

Tanja Gulder

Tobias Gulder

Anna Hirsch

Rebekka Burkholz

Mario Fritz

Jilles Vreeken

Verena Wolf

Robert Bals

Sören Becker

Martina Sester

Ulrich Boehm

Matthias Laschke

Markus Meyer

Christine Beemelmanns

Alexey Gurevich

Rolf Müller

Andriy Luzhetskyy

Wilfried Weber

Christoph Wittmann

Participating Researchers (PRs)

Martin EmptingFragment-based drug discovery and multiparameter optimization of SMs
Markus HothAnalysis of cytolytic cells, specifically in immune-cytotoxicity measurements
Alexandra K. KiemerExtracellular vesicles as DDSs and target identification and validation using CRISPR-based technologies
Dietrich KlakowLanguage models and variants, ML, and deep neural networks
Gabriela Krasteva-ChristNeuronal–epithelial cell interactions and response to infection/inflammation
Jörn M. SchattenbergPatient cohorts and samples from gastrointestinal cancer and metabolic diseases, experience in conducting clinical drug trials
Bruno SchellerDevice-based local drug-delivery systems, clinical trials
Dora TangCell-free systems, primitive gene circuits, and synthetic cells as DDSs
Lorenz ThurnerB-cell biology and antibody engineering for lymphoproliferative diseases and hyperinflammation, experience in conducting hemato-oncological drug trials
Alexander TitzCarbohydrate-based drug discovery to tackle bacterial biofilm formation
Isabel ValeraFAIR and explainable ML algorithms for multi-objective/task learning
Daniela YildizNew in vitro, in vivo and ex vivo preclinical models, including organoids
Tim MeyerSamples and data of young, healthy individuals (e.g., athletes) for metagenomic and microbiome studies
Thorsten LehrTranslating biological systems and drug dynamics to mathematical models for dose and formulation recommendations
Stefan RupfEffects of therapeutics on oral microbiome and biofilm formation
Sandra IdenCell–cell communication and biophysical-barrier analysis and drug responses
Sigrun SmolaPatient-derived, cell-based models for antiviral screening and validation
Olga KalininaNovel algorithms for protein-structure prediction, comparison, and analysis

nextGENERATION (nGR)